A Hitchhiker's Guide to Worldwide COVID-19 Vaccinations: A Detailed Review of Monovalent and Bivalent Vaccine Schedules, COVID-19 Vaccine Side Effects, and Effectiveness Against Omicron and Delta Variants

被引:11
|
作者
Goyal, Lokesh [1 ]
Zapata, Miana [2 ]
Ajmera, Kunal [3 ]
Chaurasia, Prabal [4 ]
Pandit, Ramesh [5 ,6 ]
Pandit, Trupti [7 ]
机构
[1] CHRISTUS Spohn Hosp Corpus Christi Shoreline, Hosp Med, Corpus Christi, TX 77407 USA
[2] Univ Incarnate Word Sch Osteopath Med, Internal Med, Corpus Christi, TX USA
[3] Hosp Med, Sentara Northern Virginia Med Ctr, Woodbridge, VA USA
[4] Mary Washington Hosp, Dept Hosp Med, Fredericksburg, VA USA
[5] Medicine, Philadelphia, PA USA
[6] Univ Penn, Hosp Med, Chester Cty Hosp, Philadelphia, PA USA
[7] Nemours Childrens Hlth, Pediatrics, Glen Mills, PA USA
关键词
bivalent covid-19 vaccine booster; wiv04 and hb02; gam-covid-vac; sputnikv; ad5-based covid-19 vaccine; astrazeneca; moderna; pfizer; delta variant; omicron variant; covid-19; vaccination; HOSPITALIZATIONS; PREVENTION; INFLUENZA; ADULTS; STATES;
D O I
10.7759/cureus.29837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
For the primary prevention of coronavirus disease 2019 (COVID-19), there are currently four different vaccines available in the USA. These are Pfizer (messenger RNA [mRNA]), Moderna (mRNA), Novavax (recombinant protein), and Jansen/Johnson & Johnson (adenoviral vector). All individuals should get vaccinated, and the Centers for Disease Control and Prevention (CDC) has provided comprehensive guidelines on recommended doses, their frequency by age group, and vaccine types, all discussed in detail in this article. Vaccines are a critical and cost-effective tool for preventing the disease. Prior to receiving a vaccine, patients should get adequate counseling regarding any potential adverse effects post vaccination. Appropriate safety precautions must be taken for those more likely to experience adverse consequences. Healthcare professionals should be aware of the symptoms, indicators, and treatment of any adverse event post-vaccination. We have provided a comprehensive review of the different characteristics of COVID-19 vaccines available in the United States, including their effectiveness against various variants, adverse effects, and precautions necessary for healthcare professionals and the general population. This article also briefly covers COVID-19 vaccines available worldwide, specifically their mode of action and effectiveness.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
    Li, Wanting
    Zhao, Tiantian
    Tao, Bai
    Zhao, Liwei
    Xiao, Hang
    Ding, Xinyu
    Li, Chuang
    Chen, Lin
    Cheng, Hao
    Lou, Yang
    Chen, Yuxin
    Wu, Chao
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [2] A Bivalent Omicron-Containing Booster Vaccine against Covid-19
    Chalkias, Spyros
    Harper, Charles
    Vrbicky, Keith
    Walsh, Stephen R.
    Essink, Brandon
    Brosz, Adam
    McGhee, Nichole
    Tomassini, Joanne E.
    Chen, Xing
    Chang, Ying
    Sutherland, Andrea
    Montefiori, David C.
    Girard, Bethany
    Edwards, Darin K.
    Feng, Jing
    Zhou, Honghong
    Baden, Lindsey R.
    Miller, Jacqueline M.
    Das, Rituparna
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (14): : 1279 - 1291
  • [3] mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
    Hung Fu Tseng
    Bradley K. Ackerson
    Lina S. Sy
    Julia E. Tubert
    Yi Luo
    Sijia Qiu
    Gina S. Lee
    Katia J. Bruxvoort
    Jennifer H. Ku
    Ana Florea
    Harpreet S. Takhar
    Radha Bathala
    Cindy Ke Zhou
    Daina B. Esposito
    Morgan A. Marks
    Evan J. Anderson
    Carla A. Talarico
    Lei Qian
    [J]. Nature Communications, 14
  • [4] mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
    Tseng, Hung Fu
    Ackerson, Bradley K.
    Sy, Lina S.
    Tubert, Julia E.
    Luo, Yi
    Qiu, Sijia
    Lee, Gina S.
    Bruxvoort, Katia J.
    Ku, Jennifer H.
    Florea, Ana
    Takhar, Harpreet S.
    Bathala, Radha
    Zhou, Cindy Ke
    Esposito, Daina B.
    Marks, Morgan A.
    Anderson, Evan J.
    Talarico, Carla A.
    Qian, Lei
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [5] COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization
    Piche-Renaud, Pierre-Philippe
    Swayze, Sarah B.
    Buchan, Sarah
    Wilson, Sarah B.
    Austin, Peter Z.
    Morris, Shaun
    Nasreen, Sharifa E.
    Schwartz, Kevin M.
    Tadrous, Mina
    Thampi, Nisha H.
    Wilson, Kumanan E.
    Kwong, Jeffrey
    [J]. PEDIATRICS, 2023, 151 (04)
  • [6] Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
    Solera, Javier T.
    Ierullo, Matthew
    Arbol, Berta G.
    Mavandadnejad, Faranak
    Kurtesi, Alexandra
    Qi, Freda
    Hu, Queenie
    Gingras, Anne-Claude
    Ferreira, Victor H.
    Humar, Atul
    Kumar, Deepali
    [J]. LANCET INFECTIOUS DISEASES, 2023, 23 (08): : E266 - E267
  • [7] COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis
    John, Binu, V
    Bastaich, Dustin R.
    Ferreira, Raphaella D.
    Doshi, Akash
    Taddei, Tamar H.
    Kaplan, David E.
    Spector, Seth
    Deng, Yangyang
    Dahman, Bassam
    [J]. GUT, 2023, 72 (09) : 1800 - +
  • [8] COVID-19 VACCINE EFFECTIVENESS AND COMMUNITY PREVALENCE OF ALPHA, DELTA AND OMICRON VARIANTS IN PATIENTS WITH CIRRHOSIS
    John, Binu V.
    Bastaich, Dustin R.
    Ferreira, Raphaella D.
    Doshi, Akash
    Taddei, Tamar H.
    Kaplan, David E.
    Spector, Seth A.
    Deng, Yangyang
    Dahman, Bassam
    [J]. HEPATOLOGY, 2022, 76 : S573 - S574
  • [9] COVID-19 vaccine and side effects
    Stefansdottir, Guorun
    Jacobsen, Elin I.
    Guomundsdottir, Hrefna
    [J]. LAEKNABLADID, 2021, 107 (03): : 151 - 151
  • [10] Effectiveness of Bivalent mRNA Booster Vaccine Against COVID-19 in Korea
    Yoon, Jin Gu
    Sohn, Jang Wook
    Choi, Won Suk
    Wie, Seong-Heon
    Lee, Jacob
    Lee, Jin-Soo
    Jeong, Hye Won
    Eom, Joong Sik
    Seong, Hye
    Nham, Eliel
    Choi, Yu Jung
    Noh, Ji Yun
    Song, Joon Young
    Cheong, Hee Jin
    Kim, Woo Joo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (03)